chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; abdominal pain; felt lousy; rash; sore arm; redness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash) and VACCINATION SITE PAIN (sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE, QUINAPRIL and PRAVASTATIN.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash), VACCINATION SITE PAIN (sore arm), INJECTION SITE ERYTHEMA (redness) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash), VACCINATION SITE PAIN (sore arm), INJECTION SITE ERYTHEMA (redness) and NAUSEA (nausea) outcome was unknown.            Patient used Tylenol and Pepto-Bismol for treatment of symptoms.
Initial and follow-up information has been received from a nurse practitioner concerning a 26 year old female with a history of 2 pregnancies, 2 elective terminations and 0 live births and a history of scoliosis who on 02-FEB-2007 was vaccinated with GARDASIL (Lot number 653776/0014U). Subsequently, the patient discovered she was pregnant. On 06-MAR-2007, the patient underwent an ultrasound because she was unsure of her last menstrual period which revealed an intrauterine pregnancy, 9 weeks, 2 days. Her last menstrual period was determined to be 28-DEC-2006, with an expected delivery date of 07-OCT-2007. On 20-MAR-2007 the patient developed a urinary tract infection and was treated with KEFLEX qid x 7 days. On an unspecified date it was reported that the patient had a 3 hour glucose tolerance test performed, which showed elevated value. The patient's gestational diabetes mellitus did not require insulin therapy. On 02-OCT-2007 the patient delivered a normal, healthy baby girl with no congenital anomalies weighing 6 lbs 4 oz (length not reported). Apgar scores were 7 and 9. The patient experienced a post partum hemorrhage (not further specified). Additional information is not expected.
Systemic: Fever-Severe, Systemic: hypotension, dyspnea-Severe; symptoms lasted 1 day
After both administrations, severe chills, slight fever, weakness, severe headache, and severe body aches onset within 8-12 hours and lasted for nearly 48 hours.
back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Back pain.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (back pain). At the time of the report, BACK PAIN (back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered BACK PAIN (back pain) to be unlikely related.    The patient states that she has history of back pain and currently having back pain, but it is not a side effects from vaccine.  No concomitant medications were reported. Treatment medications were not provided by the reporter.
Welt approximately 50 cent size at site of injection. Instructed mother to use hydrocortisone cream at the site.
Periprosthetic fracture of knee  - The patient  was hospitalized for a total of 3 nights. The hospitalization was necessary for pain control, medical care and Transfer to higher level of medical and surgical care. Ultimately, the patient was Transferred to Hospital under satisfactory medical  condition. At the time of release, vital signs were stable, there were no signs or symptoms of DVT and the patient was voiding. ED visit to hospital admission within 6 weeks of receiving the CVOID vaccine.
On the third day after vaccination I lost hearing in my left ear almost entirely. I am experiencing severe tinnitus and feel pressure in my left ear.
Collapsed from standing. Seizure-like activity. Concussion. Prolonged post-ictal period.
I did not have an adverse reaction to the vaccine. I have had heart failure since 2021. I went to my doctor and was referred to a cardiologist. I had been having shortness of breath. I was diagnosed with AFIB in 12/2022. I had tested positive for COVID-19 in 01/2022. I had a very mild case with a drippy nose and sneezed. I did not require a prescription and I just self-isolated.
This spontaneous report as received from a medical assistant worker refers to unspecified number of patients of unknown age and gender. The reporter stated that PNEUMOVAX23 was improperly stored and administered (dose, units, anatomical location, route of administration, lot number were not reported) to unspecified number of patients on unspecified dates. This is one of several reports from the same reporter. Additional information has been requested.
Local vaccine reaction. Left shoulder to bend of elbow red, warm, indurated, mildly tender to touch about 9cm in width around mid arm.
Fever 102.9, headache, body aches, nausea - treated with ibuprofen and fluids
Pt was vaccinated at a clinic.  Pt reports that while sitting in her observation time on March 1 at clinic, she started to experience physical neck swelling, and chest tightness, but did not report to the monitor at that time. The Pt arrived  for her 2nd dose of Moderna on 3/29/21. Pt then reports that she had neck swelling and chest pain for the next 9 days post her 1st dose. Initially the Pt denied having talked with her doctor during that time. I called Dr. to consult with him about if we were able to administer vaccination to this Pt today. Pt denied troubles breathing or swallowing, rash, N/V/diarrhea, but did state she tool her inhaler and Benadryl because of the chest tightness she was experiencing. Per Dr., he states to no give this Pt her 2nd dose of vaccination at this time as she had a mild anaphylactic reaction to the 1st dose of vaccination. Pt was not given 2nd dose and educated to consult with her physician to determine if and where appropriate to receive 2nd dose.
Was never so sick in my life; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information was provided as follows: The age at vaccination was not reported. The doctor said the patient was old and need to get a flu shot. The vaccine was received 3 years before reporting and the patient was never so sick in his/her life. The patient did get one after that dose and been just fine.
Pt had a positive COVID test on 6/14/22 at the local Clinic. Physician was Dr.  pt passed away at home; no medical records
Fever, dizziness, inability to sleep, muscle pain and weakness, headache.  All more than 24 hours.  No treatment as of yet, but possible doctor's visit soon if symptoms continue.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 59-year-old female patient who received SHINGRIX for prophylaxis. On 2nd May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever and feels awful. On an unknown date, the outcome of the fever and feels awful were recovered/resolved. It was unknown if the reporter considered the fever and feels awful to be related to SHINGRIX. Additional information received as follows: The patient felt horrible and had a fever (body temperature 102 degree F) for one day after her SHINGRIX injection. Lab Comments: In 2018, the patient's body temperature was recorded as 102 degree F.
Pt recvd 3rd dose of Engerix-B & on 14AUG90 exp HBSAB neg; 4th dose vax given 13SEP90;
Pt stated that the vaccine was administered incorrectly (not in the muscle) and that he has suffered an injury as a result. Patient did not stated that if went for any treatment or still having pain per my knowledge
PATIENT RECEIVED VACCINE ON 06/15/2022 AND CAME BACK FOR SECOND DOSE BEFORE 21 DAYS. WAS GIVEN SECOND DOSE ON 06/24/2022 BEFORE FILLING OUT CARD AND SEEING DATES
Could not sleep for 2 nights (Thursday and Friday). Fever, chills, top fever 102.1; splitting headache that was worse when I tried to lie down, so ended up resting in a reclining chair but unable to sleep. Fatigue. Loss of appetite. Very thirsty. Arm where injection received was tender and started to ache within a couple of hours of the injection. Tenderness and aching in arm continued for three days. Fever resolved on 2/20/21. Was able to sleep that night.
This spontaneous report as received from a health care worker refers to unspecified number of patients of unknown age and unknown gender. The patient's pertinent medical history was not reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored PROQUAD, (dose/frequency: 0.5 ml) subcutaneously (SQ). No adverse effects were reported. No product quality complaint (PQC) was reported for PROQUAD. This case is linked to case # 1412USA005653 (same reporter link). Additional information has been requested.
Patient was supposed to get Tdap but ended up with DTaP.  Patient has pain at injection site only.
Narrative: Bilat PEs. Dx 8/30/21 after 5d hx of acute SOB and tachycardia. Sent to ER for eval, chest CT showed submassive bilateral pulmonary emboli. On that day also found to be in Afib, new onset. COVID testing was negative. He had Neg Doppler US of his legs. ECHO did not reveal any cardiac source of thrombus. He has no known personal or FH of coagulopathy. CT on 10/12 showed no acute PE remaining.
MA administered COVID-19 vaccine 14 days prior to patient being due for 2nd booster vaccine. No adverse events noted at time of administration or 15 minutes thereafter. Patient reports no adverse events since time of administration as of this report.
Early period by 12 days; Was brown from old blood and came on very lightly.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 30Apr2021 at 16:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Apr2021 at 16:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient previously took latex (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 13:00 the patient experienced early period by 12 days and was brown from old blood and came on very lightly. It was stated that the patient had no cramps for the first 42 hours. The clinical outcome of the event early period by 12 days and was brown from old blood and came on very lightly was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
During shot administration (which was angled from the bottom, up rather than straight in), I felt burning. The injection site bled, and the nurse had to staunch it a bit. Injection site burned/stung as I drove away to wait in line in the parking lot and for a few more minutes. Then my arm swole up around the injection site to a size of about a silver dollar and maybe 1 cm high. Four nurses monitored me, including the one who gave the shot, but she did not talk and stood slightly behind my driver's side window. They let me go after maybe 25 minutes of monitoring and making sure I was OK, and what seemed like the head nurse gave me her phone number and asked me to report in in 24 and 48 hours to let them know how I was doing.  I reported 24 hours later that I developed a 99* to 100* fever, chills, and slightly achy joints over night and experienced that for one day. I texted again around 48 hours to let her know those symptoms were gone, I felt a little dizzy now and again, and I developed a bruise around the injection site. I took a photo and texted that to her. She was very kind in asking me to report my adverse effects and get care if needed.  As of this typing, 10 days later, I still have a slight bruise, and I have experienced heartbeat lapses once or twice a day. Yesterday (9 days after shot), I was sitting on the toilet resting (not exerting) and felt my heart beat hard four times slightly faster than it was at resting pace. I've experienced minor dizziness off and on but not fainted or blacked out.
had her shingrix shots about 16 months apart; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient had her shingrix shots about 16 months apart, which led to lengthening of vaccination schedule. Her doctor wanted her to do another series of the two doses so they are the 2 and 6 months. Chat got disconnected and no information other than this phrase was gathered. The reporter did not consent to follow-up.
Red swollen nodule over smallpox vax site. Pustular drainage after aspiration.
Two (2) days after receiving the 1st vaccine shot I began having  pulse irregularities being detected when taking my blood pressure. The detection has occurred 4 times in the last 2 weeks. I have never received this detection previously.
stroke; vision loss; Bell's Palsy; paralysis; severe nerve and muscle pain; severe nerve and muscle pain; neurological injury; Information has been received from a lawyer regarding a case in litigation referring to a female patient of unknown age. Information about medical history, concurrent condition and concomitant medication was not reported. On 24-AUG-2017, the patient was inoculated with Zoster Vaccine Live (ZOSTAVAX) at a pharmacy for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving Zoster Vaccine Live (ZOSTAVAX), in December 2017, the patient suffered debilitating injuries including severe nerve and muscle pain and paralysis, neurological injuries, Bell's Palsy, stroke and vision loss. These injuries were caused by Zoster Vaccine Live (ZOSTAVAX) and resulted in hospitalization and medical treatment. These symptoms lasted for months and greatly diminished the patient's quality of life and ability to function. As a direct and proximate result of Zoster Vaccine Live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using Zoster Vaccine Live (ZOSTAVAX) and caused by the Zoster Vaccine Live (ZOSTAVAX). The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of Zoster Vaccine Live (ZOSTAVAX), the patient sustained severe and debilitating personal injuries. Further, as a tragic consequence of Zoster Vaccine Live (ZOSTAVAX), the patient suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Zoster Vaccine Live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events severe nerve and muscle pain and paralysis, neurological injuries, Bell's Palsy, stroke and vision loss was not recovered and the lawyer considered all the events to be related to Zoster Vaccine Live (ZOSTAVAX).   Upon internal review, the events paralysis, Bell's Palsy, stroke and vision loss were determined to be medically significant events.
Wife called pharmacy on 10/12/2018 to report patient was hospitalized with numbness and no feeling in arm and other parts of body, she called to get vaccine name, lot #, etc for hospital. She indicated she thought they would submit a VAERS but I indicated I would also to be sure. She stated he started feeling bad next day after vaccination.
Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nauseated) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced NAUSEA (Nauseated). At the time of the report, NAUSEA (Nauseated) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that she has not taken any medication to help with the symptom. She reported that she was not on any medication. She reported that nausea lasted for 3-4 days and she did not threw up. She stated that she was nauseated as she was terrified of needles.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Corrected patient initials and updated event outcome.
Shot given 7/5/07 - developed redness on arm on 7/8/07 - no other symptoms.
Patient was fully vaccinated and tested positive for covid. He was vaccinated on 12/21/20 with Pfizer BioNtech lot EJ1685 and on 1/11/21 with Pfizer BioNTech lot EJ1685. He tested positive on 3/29/21. His two roommated were positive for covid. Patient had congestion and runny nose that resolved after 5 days. He was able to come to work at day 11 of symptoms onset.
Fever, nightsweats and head and body aches, bad for 36 hrs afterward. Fogginess, slight confusion. Nightsweats continue now 72 + hrs later, along with stomach irritation, some diarrhea, and trubled sleep throughout time.
p/vax to hosp w/bloody stools,slight fever & dehydration;Dx Intussusception;enema x2 at Childrens Hosp;
At approximately 1405, nursing reported that the patient stated that she had "confusion/disorientation, headache, difficulty speaking, dizziness, right arm briefly going numb. Soreness at her joint. Vitals: T 99.4 temporal, R 16, P 102, SpO2 99% RA, BP right wrist 184/129 BP left wrist 153/106. Monitored by the facility medical director.  No treatment required.  Symptoms resolved.
After having only received the first of the three dose vaccination, Now have genital warts.  Was diagnosed approx 3.5yrs after first injection. Never received the 2nd or 3rd doses.
Patient was given Booster dose of Moderna on 11/10/2021.   First dose given 5-4-21 Second dose given 5/25/21
Leg pain; Back pain; Lips twitching; Achilles tendon pain in her left leg; back pain is almost like a spasm; This is a spontaneous report from a contactable other hcp (patient).  A 50-year-old female patient received BNT162B2 (lot number: EL1283), via an unspecified route of administration on 13Jan2021 12:04 at single dose for COVID prophylaxis. There were medical history and concomitant medications.  It was reported that the patient experienced leg pain, back pain and lips twitching after injection which occurred two days ago on 13Jan2021. Stated that leg pain is like Achilles tendon pain in her left leg and back pain is almost like a spasm. She doesn't know if this is an expected side effect. Second dose is scheduled 09Feb2021. She wants to know if she should proceed with that. The outcome of the event "lips twitching" was unknown wile for the other events was recovering. The reporter assessed the events to be related to the suspect vaccine.
It was reported that an 18 year old female pt received a Menomune A/C/Y/W-135 vaccination on 7/29/00. Reportedly, on 8/1/00, the pt developed a sore throat, a temperature of 101F, nausea and general aches. The pt was evaluated by a physician and was dx'd with a viral illness and her symptoms per the Adverse Event report, were not related to the vaccine. From additional correspondence received on 10/4/00, it was reported, "As per our telephone conversation of 9/26/00, this form was never started. Once this individual had gone to her physician, it was determined that she had a viral infection, which had nothing to do with the vaccine. Upon talking with our director and pharmacist in charge, it was determined that this was not an event to be reported." This case is closed. *F/UP report on 3/4/03: Viral infection added as adverse event coding*
felt like leg muscle failed; sore muscles; sore joints; Difficulty walking; This spontaneous case was reported by a physician and describes the occurrence of GAIT DISTURBANCE (Difficulty walking), MUSCULAR WEAKNESS (felt like leg muscle failed), MYALGIA (sore muscles) and ARTHRALGIA (sore joints) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history was not reported.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced GAIT DISTURBANCE (Difficulty walking), MYALGIA (sore muscles) and ARTHRALGIA (sore joints). On 23-Jan-2021, the patient experienced MUSCULAR WEAKNESS (felt like leg muscle failed). At the time of the report, GAIT DISTURBANCE (Difficulty walking), MUSCULAR WEAKNESS (felt like leg muscle failed), MYALGIA (sore muscles) and ARTHRALGIA (sore joints) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient received COVID Vaccine and  she experienced swelling of her lips,, We monitored her and she took her own Benadryl  tablet. Vital signs were stable , O2 Sat was 99%  After  few minutes, her swollen lips  improved , Denies Shortness of breath , no swelling of her lymph nodes and we asked her to stay but she want to leave with her mother. PA met patient and brought her back to the Observation area. PA called 911 and they  recommended to take her to an ER so she can be monitored and observed. Patient declined and signed the EMS form that she declined to be transported by EMS.. She declined to go with the ambulance. She went home with her mother